Heska Corp (NASDAQ:HSKA) announced that Robert Grieve, Executive Chair, will present at the 15th Annual B. Riley Investor Conference at 9 a.m. PT on May 19, 2014. The conference will be held May 19-21, 2014 at Loews Santa Monica Beach Hotel, 1700 Ocean Avenue, Santa Monica, CA. Mr. Grieve will be available during the day on May 19, 2014 for one-on-one meetings. To schedule a one-on-one meeting, please contact your B. Riley representative. Heska Corp (NASDAQ:HSKA) net profit margin is -1.50% and weekly performance is -3.18%.On last trading day company shares ended up $10.65. Analysts mean target price for the company is $13.42. Heska Corp (NASDAQ:HSKA) distance from 50-day simple moving average (SMA50) is -0.14%.
Foundation Medicine, Inc. (NASDAQ:FMI) announced that 17 abstracts highlighting new clinical data on Foundation One(R) and Foundation One Heme will be presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 30-June 3, 2014 in Chicago. Foundation Medicine Inc (NASDAQ:FMI) shares fell -2.96% in last trading session and ended the day on $20.36. FMI Gross Margin is 59.70% and its return on assets is -39.60%. Foundation Medicine Inc (NASDAQ:FMI) quarterly performance is -32.29%.
Covance Inc. (NYSE:CVD) announced that it will present at the UBS Global Healthcare Conference on Tuesday, May 20, 2014 at 10:00 a.m. (ET).Covance Inc. (NYSE:CVD) shares moved up 0.74% in last trading session and was closed at $84.67, while trading in range of $83.80 – $85.27. Covance Inc. (NYSE:CVD) year to date (YTD) performance is -3.85%.
Laboratory Corp. of America Holdings (NYSE:LH) The 2014 Annual Meeting of Stockholders (the “Annual Meeting”) was held on May 14, 2014. As of March 17, 2014, the date of record for determining the Company’s stockholders entitled to vote on the proposals presented at the Annual Meeting, there were 85,017,972 shares of the Company’s common stock issued and outstanding and entitled to vote at the Annual Meeting. The holders of 73,739,860 shares of the Company’s issued and outstanding common stock were represented in person or by proxy at the Annual Meeting, constituting a quorum. Laboratory Corp. of America Holdings (NYSE:LH) ended the last trading day at $99.34. Company weekly volatility is calculated as 0.97% and price to cash ratio as 24.86. Laboratory Corp. of America Holdings (NYSE:LH) showed a negative weekly performance of -0.84%.
On 13 MAY 2014 CombiMatrix Corp (NASDAQ:CBMX) announced that Long Island Pathology (LI Path) is now offering its patients CombiMatrix’s chromosomal microarray analysis (CMA) testing for miscarriage analysis. LI Path, based in East Setauket, New York, is a physician-led diagnostic pathology laboratory serving the New York, New Jersey and northeastern Pennsylvania areas. CombiMatrix Corp (NASDAQ:CBMX) weekly performance is 1.43%.On last trading day company shares ended up $2.13. Analysts mean target price for the company is $3.40. CombiMatrix Corp (NASDAQ:CBMX) distance from 50-day simple moving average (SMA50) is -24.21%.